MedTrace Logo

The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease

NCT02501668 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1375842

Last updated 2015-07-17

No results posted yet for this study

Summary

The investigators will evaluate the prevalence of lung cancer associated with interstitial lung disease (ILD) and idiopathic pulmonary fibrosis (IPF) utilizing the Korean Health Insurance Review and Assessment Service (HIRA) database, spanning the period from January 2011 to December 2011. The database (HIRA-NPS-2011-0001) was based on random sampling of outpatients from whole population. Patients with ILDs, IPF, connective tissue disorder (CTD), and COPD were identified based on the International Classification of Disease-10 (ICD-10) diagnostic codes.

Conditions

Sponsors & Collaborators

  • Keimyung University Dongsan Medical Center

    lead OTHER

Principal Investigators

  • Won-Il Choi, MD · Keimyung Unversity Dongsan Medical Center

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02501668 on ClinicalTrials.gov